Back to search
FDAFDA · Food and drugs·Recall number D-0319-2019

Omnipaque (iohexol) Injection, 180mgI/mL, 20 mL Single-Dose Vial, packaged in 10 x 20 mL Vials per carton, Rx only, Distributed by GE Healthcare Inc., Marlborough, MA 01752 U.S.A.; Manufactured by GE Healthcare AS, Oslo, Norway; NDC 0407-1411-20.

Published December 26, 2018 · Recall initiated: October 29, 2018

Summary

FDA records drug Class II recall D-0319-2019, published December 26, 2018 and initiated October 29, 2018. Recalling firm: GE Healthcare Inc. Life Sciences; Status: Terminated; Reported quantity: 1092 cartons; Lot: Lot #: 14301544, Exp 21Sep21. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Defective Container: vial defect was identified that could potentially impact the container closure and result in a lack of sterility assurance and/or the potential for glass particles.

What to do

Voluntary: Firm initiated · Letter

Get an email if OMNIPAQUE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
OMNIPAQUE
Manufacturer
GE Healthcare Inc. Life Sciences
Distributor
TN
Lot
Lot #: 14301544, Exp 21Sep21
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Omnipaque (iohexol) Injection, 180mgI/mL, 20 mL Single-Dose Vial, packaged in 10 x 20 mL Vials per carton, Rx only, Distributed by GE Healthcare Inc., Marlborough, MA 01752 U.S.A.; Manufactured by GE Healthcare AS, Oslo, Norway; NDC 0407-1411-20. recalled?

Yes. FDA published recall D-0319-2019 on December 26, 2018. Reported hazard: Defective Container: vial defect was identified that could potentially impact the container closure and result in a lack of sterility assurance and/or the potential for glass particles.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: OMNIPAQUE.